Your browser doesn't support javascript.
loading
BMSC Alleviates Dry Eye by Inhibiting the ROS-NLRP3-IL-1ß Signaling Axis by Reducing Inflammation Levels.
Zhao, Dandan; Zhao, Hongxia; He, Yang; Zhang, Meixia.
Afiliación
  • Zhao D; Ophthalmology Department, Yan'An Hospital of Kunming City, Kunming, China.
  • Zhao H; Ophthalmology Department, Yan'An Hospital of Kunming City, Kunming, China.
  • He Y; Ophthalmology Department, Yan'An Hospital of Kunming City, Kunming, China.
  • Zhang M; Ophthalmology Department, West China Hospital of Sichuan University, Chengdu, China.
Curr Eye Res ; 49(7): 698-707, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38450655
ABSTRACT

PURPOSE:

Bone marrow mesenchymal stem cells (BMSC) have multiple biological functions and are widely involved in regulating inflammatory diseases, tissue repair and regeneration. However, the mechanism of their action in dry eye disease (DED) is currently unclear. The purpose of this study was to investigate the effect of BMSCs in the treatment of dry eye mice and to explore its specific therapeutic mechanism.

METHODS:

Mouse corneal epithelial cells (MCECs) were treated with 500 mOsM sodium chloride hypertonic solution to induce a DED cell model. The dry eye animal model was constructed by adding 5 µL 0.2% benzalkonium chloride solution to mouse eyes. Western blotting was used to detect the expression of related proteins, and flow cytometry, enzyme-linked immunosorbent assay (ELISA), terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining, hematoxylin-eosin (HE) staining, and periodic acid schiff (PAS) staining were used to detect cell and eye tissue damage.

RESULTS:

The experimental results showed that BMSCs can reduce the levels of reactive oxygen species (ROS) and inflammatory factors in MCECs, promote cell proliferation, inhibit cell apoptosis, improve the integrity of the corneal epithelial layer in vivo, promote an increase in the number of goblet cells, and alleviate DED. Further exploration of the molecular mechanism of BMSCs treatment revealed that BMSCs alleviate the progression of DED by inhibiting the ROS-NLRP3-IL-1ß signaling pathway.

CONCLUSION:

BMSCs inhibit ROS-NLRP3-IL-1ß signaling axis, reducing inflammation levels and alleviating dry eye symptoms. These findings provide new ideas and a basis for the treatment of DED and provide an experimental basis for further research on the application value of BMSCs in alleviating DED.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes de Ojo Seco / Transducción de Señal / Especies Reactivas de Oxígeno / Epitelio Corneal / Modelos Animales de Enfermedad / Interleucina-1beta / Células Madre Mesenquimatosas / Proteína con Dominio Pirina 3 de la Familia NLR Límite: Animals Idioma: En Revista: Curr Eye Res Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes de Ojo Seco / Transducción de Señal / Especies Reactivas de Oxígeno / Epitelio Corneal / Modelos Animales de Enfermedad / Interleucina-1beta / Células Madre Mesenquimatosas / Proteína con Dominio Pirina 3 de la Familia NLR Límite: Animals Idioma: En Revista: Curr Eye Res Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido